Sign In
Get Clay Free →

Suggestions

    Hannah Sore

    Co-Founder / CEO at PharmEnable

    Hannah Sore is a highly accomplished medicinal chemist and entrepreneur, best known as the CEO and co-founder of PharmEnable, a prominent drug discovery company specializing in next-generation small molecule drugs.

    PharmEnable, a spinout from Cambridge University and integral part of the Cambridge Cluster in the UK, secured £1.8m in seed financing in 2020 to propel its early stage drug discovery initiatives, blending medicinal chemistry with an exclusive AI platform.

    With an extensive background in life sciences and drug discovery, Hannah's prior roles include tenures at distinguished organizations such as Millennium Pharmaceuticals, Astex Therapeutics, and the University of Cambridge. She also brings over a decade of consulting and business expertise from Frost & Sullivan and HFS Scientific Ltd.

    Hannah Sore completed her PhD in Organic Chemistry at the University of Cambridge and holds an MSci in Chemistry from Durham University. Her diverse professional journey encompasses roles ranging from a Post Doctoral Researcher at University of Cambridge to a Healthcare Consultant at Frost & Sullivan, reflecting her versatile skill set and knowledge.

    Notable past positions held by Hannah include Co-Founder / CEO at PharmEnable, Founder / Director at HFS Scientific, Research Manager at University of Cambridge, and Research Associate roles at leading pharmaceutical companies like Astex Therapeutics and Millennium Pharmaceuticals.

    Hannah Sore
    Add to my network

    Location

    Greater Cambridge Area